Neglected Tropical Diseases: Topic of Capitol Hill Briefing/Meetings
On June 17, Research!America hosted a Capitol Hill briefing on neglected tropical diseases in partnership with Drugs for Neglected Diseases initiative (DNDi), Global Health Technologies Coalition (GHTC), The American Society for Tropical Medicine and Hygiene, and Doctors Without Borders/Médecins Sans Frontières (MSF).
Research!America also led a series of Hill meetings last week with influential congressional offices to discuss some of the successes of USAID’s NTD program and to highlight the need for continued investments. USAID’s NTD program – which was authorized by Congress in 2006 – has helped to deliver more than 580 million treatments to approximately 260 million people through mass drug administration campaigns. We were joined by Georgetown University, Baylor College of Medicine, the Global Network for NTDs, IMA World Health and the Latin America Society for Chagas (LASOCHA). The group – which represented a broad range of partners from organizations that implement USAID NTD programs to patient advocates to leading NTD expert, Dr. Peter Hotez – discussed the importance of the USAID NTD program to their work and updated staffers on emerging issues in NTD prevention and treatment. Continue reading →
Member Spotlight: The American Society for Tropical Medicine and Hygiene
By ASTMH Executive Director Karen A. Goraleski
The American Society for Tropical Medicine and Hygiene is an international organization comprised of scientists, clinicians and program professionals who work to promote global health through the prevention and control of infectious diseases. ASTMH recognizes that global health is America’s health and America’s health is global health. It is vitally important for the broad research community – from basic through implementation and evaluation – to actively support a vibrant and innovative research enterprise. Everyone benefits from a strong U.S. investment in research. Continue reading →
Health and Economic Returns on Science and Innovation Investments for Global Health
by Morgan McCloskey, Global Health Intern and Ellie Dehoney, Vice President of Policy and Programs at Research!America. This entry was originally posted as a guest contribution to the USAID IMPACT Blog.

Doctor prepares malaria treatment. Photo credit: IMAD
In the past decade, U.S. investments in science, technology and innovation have led to critical breakthroughs in prevention, diagnosis and treatment of deadly global diseases. We now have a meningitis vaccine for African populations, a new test that can quickly diagnose drug-resistant TB and promising data indicating that a vaccine could prevent HIV infection. We have developed desperately needed new drugs for neglected diseases and have determined pathways to expand access to treatment for millions through programs like PEPFAR and USAID’s Neglected Tropical Disease (NTD) program. Continue reading →
Recognizing Public Health Heroes
On September 30, The Washington Post highlighted efforts in Haiti to eliminate lymphatic filariasis, commonly known as elephantiasis. A neglected tropical disease (NTD), elephantiasis is a parasitic infection spread by mosquitoes that can lead to swelling of the arms or legs — sometimes severely enough that individuals with the disease are stigmatized or unable to work. The good news is that elephantiasis can be prevented with anti-parasitic medicines. The Centers for Disease Control and Prevention and the U.S. Agency for International Development’s NTD program have taken a leadership role in administering these drugs in countries that are affected by elephantiasis. U.S. public health professionals have joined forces with local public health professionals and helped to organize programs, provide technical assistance and monitor progress. Through the collaborative efforts of these invaluable individuals, nine countries have already been declared free of elephantiasis. With support from the CDC and international charities, the Haitian health ministry is working hard to distribute this life-saving medication and join the list of countries free of elephantiasis.
This kind of outstanding work by public health professionals happens every day all around the world. Although there is no risk of elephantiasis in America, there are other NTDs emerging in the U.S. such as Chagas disease, West Nile virus and dengue fever. The CDC and other public health professionals play a crucial role in treating these diseases and organizing prevention and education campaigns here at home. These tireless individuals keep our drinking water safe, our air clean and our children healthy. Please join Research!America and other public health organizations in recognizing these public health heroes on November 19 for Public Health Thank You Day. For more information or to learn how you can get involved, please visit www.researchamerica.org/ph_thank_you or like our PHTD Facebook page at www.facebook.com/PHTD1.
-Morgan McCloskey, global health intern